Implementation of molecular diagnostic testing for group A streptococcal pharyngitis: considerations and challenges with a focus on point-of-care environments
In the face of increased GAS-induced disease following the end of the COVID-19 pandemic, evidence supporting the clinical validity and cost-effectiveness of MDx testing for GAS pharyngitis continues to grow. Although hurdles to implementation exist, broad-based implementation of this technology is within practical reach.
Authors
- Michael J. Loeffelholz (ORCID: https://orcid.org/0000-0003-3934-089X)
- Scott Sugden (ORCID: https://orcid.org/0009-0007-8226-9749)
Publication Details
- Journal
- Expert Review of Molecular Diagnostics
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1080/14737159.2024.2443763
- Primary Topic
- Streptococcal Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00